X4 Pharmaceuticals Inc. (XFOR)
NASDAQ · Healthcare
X4 Pharmaceuticals Inc. Net Income 2018–2025
X4 Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2018 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- X4 Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -20.2 M, a 7277.66% decrease year-over-year.
- X4 Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -75.5 M, a 114516.67% decrease year-over-year.
- X4 Pharmaceuticals Inc. annual net income for 2025 was -79.2 M, a 111.48% increase from 2024.
- X4 Pharmaceuticals Inc. annual net income for 2024 was -37.5 M, a 62.98% decrease from 2023.
- X4 Pharmaceuticals Inc. annual net income for 2023 was -101.2 M, a 7.78% increase from 2022.
- X4 Pharmaceuticals Inc. annual net income for 2022 was -93.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
X4 Pharmaceuticals Inc. Net Income — FAQ
X4 Pharmaceuticals Inc. (XFOR) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is X4 Pharmaceuticals Inc.'s net income?
X4 Pharmaceuticals Inc. (XFOR) reported net income of -$79M for fiscal 2025.
Where can I see XFOR's net income history?
The chart and table above show X4 Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.